Orange County Employees Retirement System
Institutional investorFind your way into Orange County Employees Retirement System
✨ Fox Verdict
Sign up to see your fitFund commitments · as a limited partner · 230
as of Sep 2025Private-fund positions this organization discloses in its own public filings and reports — $6.5B committed, $4.1B reported NAV. Returns are this LP's own position, net of fees.
| Fund | Manager | Vintage | Committed | NAV | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|---|---|
| Orchard Landmark | Orchard Landmark | 2013 | $120M | $21.8M | 7.9% | 1.80x | — |
| Orchard Landmark II | Orchard Landmark | 2016 | $100M | $72M | 8.8% | 1.60x | 0.11x |
| Orchard Landmark IIr | Orchard Landmark | 2016 | $100M | $71.7M | 9.1% | 1.60x | 0.11x |
| Park Square Capital Credit Opportunities II | Park Square Capital | 2013 | $100M | — | 5.4% | 1.30x | 0.16x |
| Abbott Capital Private Equity Investors 2007 | Abbott | 2007 | $75M | $3.5M | 9.9% | 1.70x | 0.35x |
| Abbott Capital Private Equity Investors 2008 | Abbott | 2008 | $75M | $9.1M | 11.8% | 1.90x | 0.40x |
| Abbott Capital Private Equity Investors 2009 | Abbott | 2009 | $75M | $12.2M | 13.1% | 1.90x | 0.41x |
| Abbott Capital Private Equity Investors 2010 | Abbott | 2010 | $75M | $30.2M | 13.9% | 2.10x | 0.36x |
| Harvest Partners IX | Harvest | 2021 | $75M | $34.7M | 6.0% | 1.10x | 0.10x |
| Harvest Partners IXO | Harvest | 2021 | $75M | $31.9M | 4.5% | 1.10x | 0.09x |
| Harvest Partners VIII | Harvest Partners VIII | 2019 | $75M | $74.6M | 12.1% | 1.50x | 0.57x |
| Hellman & Friedman Capital Partners X, L.P. | Hellman & Friedman | 2021 | $75M | $77.8M | 5.6% | 1.20x | 0.11x |
| Thoma Bravo Fund XIII | Thoma Bravo | 2018 | $75M | $88.7M | 21.9% | 2.00x | 1.01x |
| Thoma Bravo Fund XIIIr | Thoma Bravo | 2018 | $75M | $92.3M | 23.0% | 1.90x | 0.95x |
| Thoma Bravo Fund XV | Thoma Bravo | 2022 | $75M | $87.3M | 14.0% | 1.40x | 0.04x |
| THOMA BRAVO XIV LP | Thoma Bravo | 2020 | $75M | $73.2M | 6.4% | 1.20x | 0.34x |
| Vista Equity Partners Fund VII L.P. | Vista Equity Partners | 2018 | $75M | $80.1M | 4.8% | 1.20x | 0.10x |
| Vista Equity Partners Fund VIIr | Vista Equity Partners | 2018 | $75M | $84.2M | 4.9% | 1.20x | 0.10x |
| Monroe Capital Private Credit Fund II | Monroe | 2015 | $70M | $10.7M | 8.9% | 1.50x | 1.29x |
| The Eighth Cinven Fund | Cinven | 2022 | $65.2M | $12.8M | — | 1.10x | — |
| Advent International GPE XI SCSp | Advent International | — | $65M | — | — | — | — |
| Clearlake Capital Partners VIII | Clearlake Capital Group | 2023 | $60M | $2.3M | — | 0.80x | 0.00x |
| Clearlake Capital Partners VIIIO | Clearlake Capital Group | 2024 | $60M | $3M | — | 0.70x | 0.00x |
| Mesirow Financial Private Equity Fund IV | Mesirow | 2006 | $60M | $7.6M | 10.8% | 2.00x | 0.12x |
| Mesirow Financial Private Equity Fund V | Mesirow | 2008 | $60M | $19.9M | 15.7% | 2.40x | 0.35x |
| Mesirow Financial Private Equity Fund VI | Mesirow | 2013 | $60M | $48.5M | 18.6% | 2.60x | 1.74x |
| Stellex Capital Partners III | Stellex Capital Management | 2024 | $60M | $10.5M | — | 0.80x | 0.01x |
| Nordic Capital Fund XII | Nordic Capital | — | $50.7M | — | — | — | — |
| Seventh Cinven Fund | Cinven | 2019 | $50.5M | $57.7M | 8.9% | 1.30x | 0.14x |
| Seventh Cinven Fundr | Cinven | 2019 | $50.5M | $59.6M | 10.9% | 1.40x | 0.24x |
| Abbott Capital Private Equity Investors 2012 | Abbott | 2012 | $50M | $31.4M | 15.5% | 2.20x | 1.60x |
| Accel - KKR Capital Partners VI, LP | Accel-KKR | 2019 | $50M | $50.7M | 6.0% | 1.20x | 0.13x |
| Advent International GPE X | Advent International | 2022 | $50M | $38M | 18.9% | 1.40x | — |
| American Industrial Partners Fund VIII | American Industrial Partners | 2023 | $50M | $31.6M | — | 1.20x | 0.05x |
| H.I.G. Advantage Buyout Fund | H.I.G. Capital | 2017 | $50M | $54M | 7.9% | 1.30x | 0.26x |
| H.I.G. Advantage Buyout II | H.I.G. Capital | 2022 | $50M | $11.9M | 15.1% | 1.30x | 0.14x |
| H.I.G. Middle Market LBO Fund IV | H.I.G. Capital | 2022 | $50M | — | -43.5% | 0.60x | 0.03x |
| H.I.G. Middle Market LBO Fund IVO | — | 2022 | $50M | — | -24.4% | 0.80x | 0.02x |
| Hellman & Friedman Capital Partners XI, L.P. | Hellman & Friedman | 2022 | $50M | — | — | — | — |
| Linden Capital Partners VI | Linden Capital | — | $50M | — | — | — | — |
| Oak HC-FT Partners IV | Oak HC/FT | 2021 | $50M | $66.1M | 9.1% | 1.30x | 0.00x |
| Oak HC-FT Partners V-A | Oak HC/FT | 2022 | $50M | $32.3M | 14.8% | 1.20x | 0.21x |
| Oak HC-FT Partners VI LP | Oak HC/FT | — | $50M | — | — | — | — |
| One Rock Capital Partners III, LP | One Rock Capital Partners | 2021 | $50M | $42.1M | 24.5% | 1.80x | 0.91x |
| One Rock Capital Partners IV | One Rock Capital Partners | 2023 | $50M | $7.8M | — | 1.10x | — |
| Stellex Capital Partners II LP | Stellex Capital Management | 2021 | $50M | $62.1M | 15.3% | 1.40x | 0.18x |
| Thoma Bravo Fund XVI | Thoma Bravo | 2024 | $50M | — | — | — | — |
| TPG Healthcare Partners II, L.P. | TPG | 2023 | $50M | $28.7M | — | 1.40x | 0.00x |
| Trident IX, L.P. | Trident | 2022 | $50M | $53.7M | 17.4% | 1.30x | 0.12x |
| Trident VIII, L.P. | Trident | 2020 | $50M | $62.9M | 13.4% | 1.60x | 0.31x |
| Nordic Capital Fund XI | Nordic Capital | 2022 | $49.6M | $44.4M | 25.1% | 1.30x | 0.03x |
| PAI Partners VIII-1 SCSp | PAI Partners | 2022 | $49.5M | $26.8M | 17.8% | 1.20x | — |
| Altor Fund VI | Altor | 2022 | $49M | $24.9M | 39.3% | 1.30x | 0.36x |
| Abbott Capital Private Equity Investors 2011 | Abbott | 2011 | $45M | $22.1M | 15.1% | 2.20x | 1.70x |
| Abbott Capital Private Equity Investors 2013 | Abbott | 2013 | $45M | $30.8M | 16.5% | 2.30x | 1.59x |
| Abbott Capital Private Equity Investors 2014 | Abbott | 2014 | $45M | $36M | 16.4% | 2.30x | 1.49x |
| Abbott Capital Private Equity Investors 2015 | Abbott | 2015 | $45M | $41.9M | 16.2% | 2.20x | 1.22x |
| Adams Street 2014 Global Fund | Adams Street Partners | 2014 | $45M | $42.4M | 14.0% | 2.30x | 1.27x |
| H.I.G. Capital Partners VII | H.I.G. Capital | 2025 | $45M | $400K | — | 0.40x | — |
| Vitruvian Investment Partnership V | Vitruvian Partners | 2023 | $40.3M | $15.7M | -4.9% | 1.00x | — |
| Accel-KKR Capital Partners VII, L.P. | Accel-KKR | 2023 | $40M | $1.3M | — | 0.40x | — |
| Altaris Health Partners V | Altaris | 2020 | $40M | $44.1M | 8.2% | 1.20x | 0.02x |
| Altaris Health Partners VI | Altaris | 2023 | $40M | — | — | — | — |
| Clearlake Capital Partners VII | Clearlake Capital Group | 2021 | $40M | $31.7M | 4.1% | 1.10x | 0.00x |
| Mesirow Financial Private Equity Fund VII-B | Mesirow | 2017 | $40M | $72.1M | 28.5% | 3.20x | 1.40x |
| H.I.G. Europe Middle Market LBO Fund | H.I.G. Capital | 2020 | $38.7M | $36.9M | 20.1% | 1.30x | 0.25x |
| Oakley Capital VI-B1 SCSp | Oakley | 2024 | $36.3M | $400K | — | 0.30x | 0.00x |
| Adams Street 2012 Global Fund | Adams Street Partners | 2012 | $35M | $23.6M | 12.9% | 2.20x | 1.46x |
| Adams Street Venture/Growth Fund VI | Adams Street Partners | 2015 | $35M | $31M | 6.0% | 1.50x | 0.52x |
| Genstar Capital Partners X | Genstar | 2021 | $35M | $37.8M | 4.0% | 1.10x | 0.04x |
| Genstar Capital Partners XI | Genstar | 2023 | $35M | $4.4M | — | 1.10x | 0.09x |
| Genstar Capital Partners XIr | Genstar | 2023 | $35M | $5.2M | — | 1.20x | 0.09x |
| Hg Saturn 4 A | Hg Saturn 4 A | — | $35M | $300K | — | — | — |
| Insight Partners Fund XIII | Insight Partners | 2024 | $35M | $9.1M | — | 1.10x | 0.00x |
| Spark Capital Growth Fund III | Spark | 2020 | $33.3M | $45.9M | 11.8% | 1.60x | 0.18x |
| Spark Capital Growth Fund IV | Spark | 2021 | $33.3M | $63.8M | 44.2% | 2.20x | — |
| Spark Capital Growth Fund V | Spark | 2023 | $33.3M | $21.6M | — | 1.10x | — |
| Investindustrial VIII SCSp | Investindustrial | 2024 | $32.4M | $3.6M | — | 0.90x | 0.00x |
| C-Bridge Healthcare Fund V | C-Bridge Capital | 2021 | $30M | $41.1M | 15.9% | 1.40x | 0.14x |
| Clearlake Capital Partners VI | Clearlake Capital Group | 2020 | $30M | $42.8M | 11.3% | 1.50x | 0.15x |
| DBL Partners TIAB 2018 | DBL Partners | 2019 | $30M | $95.4M | 40.4% | 9.70x | — |
| DBL Partners TIAB 2020 | DBL Partners | 2020 | $30M | $4.9M | 44.8% | 6.80x | — |
| H.I.G. Middle Market LBO Fund III | H.I.G. Capital | 2019 | $30M | $23.8M | 8.8% | 1.30x | 0.43x |
| H.I.G. Small-Cap & Growth Buyout Fund IV | H.I.G. Small-Cap & Growth Buyout | — | $30M | — | — | — | — |
| HealthQuest Partners IV | HealthQuest Capital | 2023 | $30M | $18.9M | 17.7% | 1.20x | — |
| Lightspeed Opportunity Fund III, L.P. | Lightspeed Venture Partners | 2025 | $30M | $16.3M | — | 1.50x | — |
| Orchid Asia VIII | Orchid Asia | 2021 | $30M | $19.2M | 4.5% | 1.10x | 0.26x |
| Investindustrial Growth III | Investindustrial | 2022 | $29.1M | $5.5M | — | 1.10x | — |
| Investindustrial Growth IIIr | Investindustrial | 2022 | $29.1M | $12.9M | 25.3% | 1.30x | — |
| Hg Genesis 11 A | Hg Genesis 11 A | — | $28.4M | — | — | — | — |
| Adams Street - 2007 U.S. Fund | Adams Street Partners | 2007 | $27.5M | $500K | 12.1% | 2.00x | 2.00x |
| Accel-KKR Growth Capital Partners IV | Accel-KKR | 2022 | $27M | $14.8M | 1.7% | 1.00x | — |
| FSN Capital Compass I | FSN | 2022 | $26.6M | $6.5M | — | 0.60x | — |
| ArchiMed MED Platform II | ArchiMed Pte. Ltd. | 2022 | $25.5M | $19.6M | 21.6% | 1.30x | 0.01x |
| Vitruvian Investment Partnership IV | Vitruvian Partners | 2020 | $25.1M | $31.3M | 11.0% | 1.40x | 0.07x |
| Accel-KKR Growth Capital Partners III, LP | Accel-KKR | 2018 | $25M | $28M | 8.9% | 1.30x | 0.33x |
| Adams Street - 2008 U.S. Fund | Adams Street Partners | 2008 | $25M | $200K | 15.7% | 2.30x | 2.28x |
| Adams Street - 2009 U.S. Fund | Adams Street Partners | 2009 | $25M | $8.1M | 14.8% | 2.40x | 2.02x |
| Adams Street - 2010 U.S. Fund | Adams Street Partners | 2010 | $25M | $11.6M | 16.0% | 2.60x | 2.04x |
| Adams Street 2013 Global Fund | Adams Street Partners | 2013 | $25M | $21M | 12.9% | 2.20x | 1.34x |
Largest 100 of 230 disclosed positions. Source: the organization's public disclosures. TVPI = total value / paid-in; DPI = distributions / paid-in.
Images
